|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date29 Jun 1989 |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismthrombin inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Shire Pharmaceuticals Group
0 Patents (Medical) associated with Shire Pharmaceuticals Group
100 Deals associated with Shire Pharmaceuticals Group
100 Translational Medicine associated with Shire Pharmaceuticals Group